Jian Yu, MD
Nuclear Radiology · Philadelphia, PANPI 1992728646
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Telix Pharmaceuticals at 46.4% of the total. Reporting peaked in 2024 at $3,904 and has fallen 75.0% since, to $975 in 2025.
Across 33 payments — averaging $227.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Telix Pharmaceuticals$3K
- Blue Earth Diagnostics$3K
- GE HealthCare$378
- Novartis$374
- Progenics Pharmaceuticals, Inc.$151
- Advanced Accelerator Applications$112
- plus $43 from 1 others
Across 26 payments — averaging $707.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Y-mabs Therapeutics, Inc.$18K
What the payments were for
- Consulting fees$2,96539%
- Travel & lodging$2,79737%
- Food & beverage$1,75023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Telix Pharmaceuticals | 19 | $3,489 |
| Blue Earth Diagnostics | 1 | $2,965 |
| GE HealthCare | 3 | $378 |
| Novartis | 4 | $374 |
| Progenics Pharmaceuticals, Inc. | 2 | $151 |
| Advanced Accelerator Applications | 2 | $112 |
| Sirtex Medical Inc | 2 | $43 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few nuclear radiology providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear radiology in Philadelphia
- Charles IntenzoPhiladelphia$85K
- Jacob DubroffPhiladelphia$9K
- Mark SellmyerPhiladelphia$676
- Luis AraujoPhiladelphia$227
- Bhishak KamatPhiladelphia$53
- Karen RosenspirePhiladelphia$21
- Jose Miguel Hernandez PampaloniPhiladelphia$0
- Ashok MuthukrishnanPittsburgh$13K
- Robert FournierBethlehem$3K
- Kevin SchlegelDanville$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.